Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kumi Inoue"'
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 124-135 (2021)
Antibodies specific for cardiolipin (CL)-β2-glycoprotein I (β2GPI) are known to induce tissue factor (TF) expression by monocytes and endothelial cells which leads to a prothrombotic state in antiphospholipid syndrome (APS), but the mechanism is no
Externí odkaz:
https://doaj.org/article/01df479967374dbda7921f75dac4a14a
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 124-135 (2021)
Antibodies specific for cardiolipin (CL)-β2-glycoprotein I (β2GPI) are known to induce tissue factor (TF) expression by monocytes and endothelial cells which leads to a prothrombotic state in antiphospholipid syndrome (APS), but the mechanism is no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c18e26789ed05372f2506ac9a2233a
https://doi.org/10.1080/25785826.2020.1796285
https://doi.org/10.1080/25785826.2020.1796285
Publikováno v:
Immunological medicine. 44(2)
Antibodies specific for cardiolipin (CL)-β
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::23dba025a80bbdda7bb9fd569c2f962e
https://pubmed.ncbi.nlm.nih.gov/32701417
https://pubmed.ncbi.nlm.nih.gov/32701417
Autor:
Kumi Inoue, Tetsuo Oishi
Publikováno v:
Denki Kagaku. 88:298-298
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c1ee765dd5f3084ae7a97b47ae648a9
https://doi.org/10.5796/denkikagaku.20-fe0026
https://doi.org/10.5796/denkikagaku.20-fe0026
Autor:
Katsuyoshi Ikeda, Kumi Inoue
Publikováno v:
Denki Kagaku. 88:209-209
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d292ec318704603dc824d15265918558
https://doi.org/10.5796/denkikagaku.20-fe0018
https://doi.org/10.5796/denkikagaku.20-fe0018
Autor:
Kazuha, Shosu, Masashi, Sakurai, Kumi, Inoue, Takayuki, Nakagawa, Hiroki, Sakai, Masahiro, Morimoto, Masaru, Okuda, Shunsuke, Noguchi, Takuya, Mizuno
Publikováno v:
In vivo (Athens, Greece). 30(3)
Antibody therapy targeting programmed cell death-1 (PD-1) and programmed cell death-ligand 1 (PD-L1) is a promising therapy in human cancer, but only limited information on PD-L1 expression in canine tumors is available.PD-L1 expression was examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0db5efc9b16a923c1ca57e05eb817bf9
https://pubmed.ncbi.nlm.nih.gov/27107075
https://pubmed.ncbi.nlm.nih.gov/27107075
Publikováno v:
Seibutsu Butsuri. 54:S189
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bc2d10611317fbe25db5690b9c9b141
https://doi.org/10.2142/biophys.54.s189_4
https://doi.org/10.2142/biophys.54.s189_4
Autor:
Masakari, Yosuke1 ymasakari@mail.kikkoman.co.jp, Totsuka, Naoya1, Shinohara, Yasutomo1, Yoshida, Shotaro2, Abe, Hiroya2, Ito, Kotaro1, Nishizawa, Matsuhiko2
Publikováno v:
Electrochemical Science Advances. Aug2022, Vol. 2 Issue 4, p1-6. 6p.
Autor:
Yoshino, Tadashi1 yoshino@md.okayama-u.ac.jp, Takata, Katsuyoshi1, Tanaka, Takehiro1, Sato, Yasuharu2, Tari, Akira3, Okada, Hiroyuki4
Publikováno v:
Pathology International. Dec2018, Vol. 68 Issue 12, p665-676. 12p.
Publikováno v:
Immunological Medicine; Jun2021, Vol. 44 Issue 2, p124-135, 12p